Dr. Stephen K. Klasko Is Appointed to the Nuvo Group BOD

HRS Scientific Sessions: Boston Scientific LBCT

During the Heart Rhythm Scientific Sessions this week, Boston Scientific announced positive LBCT data underscoring the safety and efficacy of multi-site pacing (MSP) over conventional cardiac resynchronization therapy (CRT), as well as poster presentations on real-world use of the WATCHMAN Left Atrial Appendage Closure (LAAC) device and next-generation WATCHMAN FLX LAAC device as alternatives to oral anticoagulation therapy for stroke risk reduction in patients with non-valvular atrial fibrillation.

What are the Most Commonly Performed Surgeries?

Whether you are trying to learn more about a surgery you are planning to have or find out what the most common procedures are, this list is here for you. Read more.

B2B Training: What’s the Most Effective Way of Learning?

B2B training, which is short for business-to-business training, is a popular and convenient type of training that enables entire companies to train their teams...

September 1, 2020

Dr. Stephen K. Klasko has been appointed to the Board of Directors of Nuvo Group. The news was announced today. He is President of Thomas Jefferson University and Chief Executive Officer of Jefferson Health.

Dr. Stephen K. Klasko brings a rare combination of experience as a former practicing OB/GYN, a pioneer in envisioning ‘a hospital with no address,’ and the CEO of a major health system at the vanguard of telehealth.

Nuvo is building the foundation of a disruption in pregnancy care delivery—a specialty that has seen little innovation in decades and is being left behind in the movement toward ‘a hospital with no address. Steve’s unparalleled vision, clinical, and operational experience makes him uniquely suited to provide insights, strategic guidance, and market connections that will help Nuvo revolutionize pregnancy care for the 21st century and create extraordinary value for all system stakeholders,” said Oren Oz, Founder and CEO of Nuvo Group.

Nuvo Group shares my vision of what the next generation of healthcare must be—namely ‘healthcare at any address,’ said Dr. Klasko. “In the United States, an emphasis on ‘sick care’ has led to pregnancy being viewed as a disease, defined by a hospital-centric model that has frustrated women at many levels and increased maternal neonatal disparities. Otherwise healthy pregnant women don’t view themselves as patients—and do not want to go where the sickest people are for testing. I look forward to contributing to the success of the INVU platform in creating a mom-centric experience that connects pregnant women and providers and forges a path toward pregnancy population health.”

Dr. Klasko is a transformative leader and advocate for a revolution who, as President and CEO of Jefferson Health since 2013, has led one of the nation’s fastest-growing academic health institutions based on his vision of re-imagining healthcare and higher education. Prior to Jefferson Health, he served as dean of two medical colleges and the leader of three academic health centers.

Dr. Klasko’s own research has focused on physician leadership. After receiving his MBA from the Wharton School of Business of the University of Pennsylvania, he developed research about selecting and educating physicians to be leaders of change. He launched a unique medical education program at the University of South Florida, called SELECT (Scholarly Excellence, Leadership Education, Collaborative Training), to choose and mentor medical students based on emotional intelligence and leadership potential.

spot_img

DON'T MISS

Mediclinic Appoints 2 New Independent Non-Executive Directors

Natalia Barsegiyan and Zarina Bassa will bring significant and diverse skills and experience, complementing those of existing Board members. I am confident they will both be great additions to our Board of Directors.”

Asensus Surgical Appoints Two New Board Members

Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the expansion of its Board of Directors, appointing...

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.